Relapse risk after autologous stem cell transplantation in patients with lymphoma based on CD34+ cell dose.
Sorigue M, Sancho JM, Morgades M, Moreno M, Grífols JR, Alonso E, Juncà J, Ferrà C, Batlle M, Vives S, Motlló C, García-Caro M, Navarro JT, Millà F, Feliu E, Ribera JM.
Sorigue M, et al. Among authors: batlle m.
Leuk Lymphoma. 2017 Apr;58(4):916-922. doi: 10.1080/10428194.2016.1222378. Epub 2016 Aug 26.
Leuk Lymphoma. 2017.
PMID: 27561733